Display options
Share it on

Sleep Disord. 2013;2013:128197. doi: 10.1155/2013/128197. Epub 2013 Mar 12.

Melatonin supplementation in patients with complete tetraplegia and poor sleep.

Sleep disorders

Jo Spong, Gerard A Kennedy, Douglas J Brown, Stuart M Armstrong, David J Berlowitz

Affiliations

  1. Institute for Breathing and Sleep, Austin Hospital, Heidelberg, VIC 3084, Australia.

PMID: 23766913 PMCID: PMC3610349 DOI: 10.1155/2013/128197

Abstract

People with complete tetraplegia have interrupted melatonin production and commonly report poor sleep. Whether the two are related is unclear. This pilot study investigated whether nightly supplementation of 3 mg melatonin would improve objective and subjective sleep in tetraplegia. Five participants with motor and sensory complete tetraplegia ingested 3 mg melatonin (capsule) two hours prior to usual sleep time for two weeks. Full portable sleep studies were conducted in participants' homes on the night before commencing melatonin supplementation (baseline) and on the last night of the supplementation period. Endogenous melatonin levels were determined by assaying saliva samples collected the night of (just prior to sleep) and morning after (upon awakening) each sleep study. Prior to each sleep study measures of state sleepiness and sleep behaviour were collected. The results showed that 3 mg of melatonin increased salivary melatonin from near zero levels at baseline in all but one participant. A delay in time to Rapid Eye Movement sleep, and an increase in stage 2 sleep were observed along with improved subjective sleep experience with a reduction in time to fall asleep, improved quality of sleep and fewer awakenings during the night reported. Daytime sleepiness increased however. A randomised, placebo controlled trial with a larger sample is required to further explore and confirm these findings.

References

  1. Spinal Cord. 2010 Jan;48(1):10-4 - PubMed
  2. Sleep Med. 2007 Sep;8(6):651-5 - PubMed
  3. Sleep. 1995 Sep;18(7):598-603 - PubMed
  4. Sleep Med Rev. 2005 Feb;9(1):51-65 - PubMed
  5. Neuropsychopharmacology. 1990 Feb;3(1):19-23 - PubMed
  6. Arch Phys Med Rehabil. 2012 Jul;93(7):1246-52 - PubMed
  7. Spinal Cord. 2006 Feb;44(2):78-81 - PubMed
  8. FASEB J. 2012 Jul;26(7):3059-64 - PubMed
  9. Lancet. 1991 May 11;337(8750):1121-4 - PubMed
  10. Paraplegia. 1994 Nov;32(11):780-6 - PubMed
  11. Neuropsychopharmacology. 1987 Dec;1(1):41-4 - PubMed
  12. Sleep Med Rev. 2005 Feb;9(1):71-80 - PubMed
  13. J Clin Endocrinol Metab. 1992 Aug;75(2):447-52 - PubMed
  14. Sleep. 1996 Jun;19(5):423-31 - PubMed
  15. Spinal Cord. 1998 Aug;36(8):554-60 - PubMed
  16. Sleep. 1994 Apr;17(3):236-41 - PubMed
  17. Pharmacol Ther. 1996;69(1):15-36 - PubMed
  18. Clin Endocrinol (Oxf). 1989 Jan;30(1):47-56 - PubMed
  19. J Clin Endocrinol Metab. 2004 Jan;89(1):128-34 - PubMed
  20. Endocrinol Jpn. 1986 Jun;33(3):405-14 - PubMed
  21. Clin Pharmacol Ther. 1995 May;57(5):552-8 - PubMed
  22. Sleep Med Rev. 2005 Feb;9(1):5-9 - PubMed
  23. N Engl J Med. 1997 Jan 16;336(3):186-95 - PubMed
  24. Spinal Cord. 2001 Oct;39(10):505-13 - PubMed
  25. PLoS One. 2008 Aug 26;3(8):e3055 - PubMed
  26. J Pineal Res. 2001 Nov;31(4):326-32 - PubMed
  27. Lancet. 1995 Dec 2;346(8988):1491 - PubMed
  28. Sleep. 1997 Oct;20(10):908-15 - PubMed
  29. J Biol Rhythms. 1998 Dec;13(6):532-8 - PubMed
  30. J Sleep Res. 1995 Jun;4(S1):150-155 - PubMed
  31. Sleep. 1999 Aug 1;22(5):667-89 - PubMed
  32. Chronobiol Int. 2006;23(1-2):475-84 - PubMed
  33. J Clin Endocrinol Metab. 2000 Jun;85(6):2189-96 - PubMed
  34. J Neural Transm Suppl. 1978;(13):311-23 - PubMed
  35. Sleep. 1998;21(1):52-68 - PubMed
  36. J Biol Rhythms. 1991 Fall;6(3):249-61 - PubMed

Publication Types